Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey

Showing results (341-350 of 651) with videos related to

Pageof 66
Sort By:
The Medical Journal of Australia|September 3, 1990
Does hepatitis C virus play a role in "non-viral" chronic liver disease?C Liddle, E B Crewe, N R Swanson, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 1999
Banff schema for grading liver allograft rejection: utility in clinical practiceD G Ormonde, W B de Boer, A Kierath, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5Andrew S Felts, Sam A Saleh, Uyen Le, et al.
Molecular Pharmacology|February 28, 2013
Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacologyKaren J Gregory, Elizabeth D Nguyen, Sean D Reiff, et al.
The American Journal of Gastroenterology|January 9, 2026
The Impact of Body Weight Change on Liver Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Across Various Histological Endpoints: A Systematic Review and Meta-AnalysisDujinthan Jayabalan, Sugam Dhakal, Jeffrey Chandra, et al.
Journal of Gastroenterology and Hepatology|April 17, 2004
Does sequencing the PKRBD of hepatitis C virus NS5A predict therapeutic response to combination therapy in an Australian population?Gerry C Macquillan, Xianwa Niu, David Speers, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 27, 2013
Image analysis of liver collagen using sirius red is more accurate and correlates better with serum fibrosis markers than trichromeYi Huang, W Bastiaan de Boer, Leon A Adams, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 22, 2003
The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behaviorGene G Kinney, Cyrille Sur, Maryann Burno, et al.
World Journal of Gastroenterology|November 30, 2016
Effect of airplane transport of donor livers on post-liver transplantation survivalYi Huang, Gerry MacQuillan, Leon A Adams, et al.
Biochemical Pharmacology|May 20, 2018
Probing the binding site of novel selective positive allosteric modulators at the M<sub>1</sub> muscarinic acetylcholine receptorElham Khajehali, Celine Valant, Manuela Jörg, et al.
Pageof 66

Showing results (341-350 of 651) with videos related to

Sort By:
Pageof 66
The Medical Journal of Australia|September 3, 1990
Does hepatitis C virus play a role in "non-viral" chronic liver disease?C Liddle, E B Crewe, N R Swanson, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 1999
Banff schema for grading liver allograft rejection: utility in clinical practiceD G Ormonde, W B de Boer, A Kierath, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5Andrew S Felts, Sam A Saleh, Uyen Le, et al.
Molecular Pharmacology|February 28, 2013
Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacologyKaren J Gregory, Elizabeth D Nguyen, Sean D Reiff, et al.
The American Journal of Gastroenterology|January 9, 2026
The Impact of Body Weight Change on Liver Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Across Various Histological Endpoints: A Systematic Review and Meta-AnalysisDujinthan Jayabalan, Sugam Dhakal, Jeffrey Chandra, et al.
Journal of Gastroenterology and Hepatology|April 17, 2004
Does sequencing the PKRBD of hepatitis C virus NS5A predict therapeutic response to combination therapy in an Australian population?Gerry C Macquillan, Xianwa Niu, David Speers, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 27, 2013
Image analysis of liver collagen using sirius red is more accurate and correlates better with serum fibrosis markers than trichromeYi Huang, W Bastiaan de Boer, Leon A Adams, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 22, 2003
The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behaviorGene G Kinney, Cyrille Sur, Maryann Burno, et al.
World Journal of Gastroenterology|November 30, 2016
Effect of airplane transport of donor livers on post-liver transplantation survivalYi Huang, Gerry MacQuillan, Leon A Adams, et al.
Biochemical Pharmacology|May 20, 2018
Probing the binding site of novel selective positive allosteric modulators at the M<sub>1</sub> muscarinic acetylcholine receptorElham Khajehali, Celine Valant, Manuela Jörg, et al.
Pageof 66